What’s different for EmblemHealth’s CEO the 2nd time around?

Advertisement

Karen Ignagni has returned to her CEO seat at EmblemHealth — and things are different this time around.

Ms. Ignagni never left the organization: Following a stint as EmblemHealth’s executive board chair, she stepped back into the CEO role as Mike Palmateer retired after nearly two years at the helm. Before Ms. Ignagni’s tenure at the insurer, she led AHIP. In the Sept. 17 announcement, the company said its board of directors will begin an executive search process.

Ms. Ignagni joined an upcoming episode of the “Becker’s Payer Issues Podcast” to discuss EmblemHealth’s evolution and the expectations for the year ahead.

The biggest difference: “When I came to EmblemHealth, it was a turnaround situation,” she said.

Group Health Incorporated and the Health Insurance Plan of Greater New York affiliated in 2006, with EmblemHealth becoming the parent organization. Ms. Ignagni began leading EmblemHealth in 2015, with financial concerns top of mind. In the years leading up to her appointment, there had been rumblings about EmblemHealth possibly transitioning to a for-profit structure, but the organization stayed nonprofit.

“We are a very important not-for-profit community mission plan in New York City,” she said. 

Like other insurers, EmblemHealth is navigating policy changes for 2027, including aspects of the interoperability rule.

“If we hadn’t modernized our technology, I wouldn’t be sleeping a wink,” Ms. Ignagni said about the interoperability rule. One cornerstone of her leadership has been ensuring EmblemHealth could compete with larger payers. This includes “all of the bells and whistles” for customer service, care management and AI.

Other concerns for 2027: Medicaid work requirements and more frequent eligibility checks.

“If you have cancer, you don’t have an automatic exemption,” Ms. Ignagni said. “That’s a head scratcher to me.”

While there will be an exclusion for the “medically frail,” the interim final rule pushed back on exemptions based on diagnosis alone.

“We do not believe it is reasonable to categorically consider conditions as serious or complex without factoring in criteria such as the severity of the condition,” the rule said.

Ms. Ignagni said EmblemHealth is focused on helping members understand these changes, including when renewals are due, what information members must provide and whether they qualify for an exemption. She emphasized the need for a strong government affairs team to keep up with requirements.

“It broadens out this role of a health plan,” she said. “It moves us into a social support mechanism.”

At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.

Advertisement

Next Up in Leadership

Advertisement